{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T04:22:20Z","timestamp":1728102140018},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,4]]},"DOI":"10.7759\/cureus.70854","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T19:12:22Z","timestamp":1728069142000},"source":"Crossref","is-referenced-by-count":0,"title":["Revisiting Left Atrial Appendage Closure Versus Oral Anticoagulants in Recurrent Atrial Fibrillation Management: An Updated Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Guilherme","family":"Requi\u00e3o Radel Neto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas","family":"Bittar de Morais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael","family":"Hideki Sheguti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Poci Liberato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.114389","article-title":"Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for embolic protection in patients with atrial fibrillation) trial","volume":"127","author":"Reddy VY","year":"2013","unstructured":"Reddy VY, Doshi SK, Sievert H, et al.. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for embolic protection in patients with atrial fibrillation) trial. Circulation. 2013, 127:720-9. 10.1161\/CIRCULATIONAHA.112.114389","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1137230","article-title":"Estimates of the global, regional, and national burden of atrial fibrillation in older adults from 1990 to 2019: insights from the Global Burden of Disease study 2019","volume":"11","author":"Jiao M","year":"2023","unstructured":"Jiao M, Liu C, Liu Y, Wang Y, Gao Q, Ma A. Estimates of the global, regional, and national burden of atrial fibrillation in older adults from 1990 to 2019: insights from the Global Burden of Disease study 2019. Front Public Health. 2023, 11:1137230. 10.3389\/fpubh.2023.1137230","journal-title":"Front Public Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2015.12.037","article-title":"Over 1-year efficacy and safety of left atrial appendage occlusion versus novel oral anticoagulants for stroke prevention in atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials and observational studies","volume":"13","author":"Li X","year":"2016","unstructured":"Li X, Wen SN, Li SN, et al.. Over 1-year efficacy and safety of left atrial appendage occlusion versus novel oral anticoagulants for stroke prevention in atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials and observational studies. Heart Rhythm. 2016, 13:1203-14. 10.1016\/j.hrthm.2015.12.037","journal-title":"Heart Rhythm"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.carrev.2021.04.019","article-title":"Left atrial appendage closure versus oral anticoagulation in non-valvular atrial fibrillation: a systematic review and meta-analysis","volume":"36","author":"Al-Abcha A","year":"2022","unstructured":"Al-Abcha A, Saleh Y, Elsayed M, et al.. Left atrial appendage closure versus oral anticoagulation in non-valvular atrial fibrillation: a systematic review and meta-analysis. Cardiovasc Revasc Med. 2022, 36:18-24. 10.1016\/j.carrev.2021.04.019","journal-title":"Cardiovasc Revasc Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2023.05.044","article-title":"An updated meta-analysis on the clinical outcomes of percutaneous left atrial appendage closure versus direct oral anticoagulation in patients with atrial fibrillation","volume":"200","author":"Jiang H","year":"2023","unstructured":"Jiang H, Koh TH, Vengkat V, et al.. An updated meta-analysis on the clinical outcomes of percutaneous left atrial appendage closure versus direct oral anticoagulation in patients with atrial fibrillation. Am J Cardiol. 2023, 200:135-43. 10.1016\/j.amjcard.2023.05.044","journal-title":"Am J Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd8060069","article-title":"Comparison of left atrial appendage occlusion versus non-vitamin-K antagonist oral anticoagulation in high-risk atrial fibrillation: an update","volume":"8","author":"Chen S","year":"2021","unstructured":"Chen S, Chun KR, Ling Z, et al.. Comparison of left atrial appendage occlusion versus non-vitamin-K antagonist oral anticoagulation in high-risk atrial fibrillation: an update. J Cardiovasc Dev Dis. 2021, 8:69. 10.3390\/jcdd8060069","journal-title":"J Cardiovasc Dev Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s40119-023-00337-2","article-title":"Left atrial appendage closure: a narrative review","volume":"12","author":"Nagasaka T","year":"2023","unstructured":"Nagasaka T, Nakamura M. Left atrial appendage closure: a narrative review. Cardiol Ther. 2023, 12:615-35. 10.1007\/s40119-023-00337-2","journal-title":"Cardiol Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati A","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al.. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009, 339:b2700. 10.1136\/bmj.b2700","journal-title":"BMJ"},{"key":"ref9","article-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011].","author":"The Cochrane Collaboration","year":"2011","unstructured":"The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. Higgins JP, Green S (ed): John Wiley & Sons, Chichester, UK; 2011. https:\/\/handbook-5-1.cochrane.org\/."},{"key":"ref10","unstructured":"The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. (2021). Accessed. September 29, 2024: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins JP","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, et al.. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011, 343:d5928. 10.1136\/bmj.d5928","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2020.09.051","article-title":"Clinical outcomes associated with left atrial appendage occlusion versus direct oral anticoagulation in atrial fibrillation","volume":"14","author":"Nielsen-Kudsk JE","year":"2021","unstructured":"Nielsen-Kudsk JE, Korsholm K, Damgaard D, Valentin JB, Diener HC, Camm AJ, Johnsen SP. Clinical outcomes associated with left atrial appendage occlusion versus direct oral anticoagulation in atrial fibrillation. JACC Cardiovasc Interv. 2021, 14:69-78. 10.1016\/j.jcin.2020.09.051","journal-title":"JACC Cardiovasc Interv"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2023.10.012","article-title":"Severity of ischemic stroke after left atrial appendage closure vs nonwarfarin oral anticoagulants","volume":"10","author":"Turagam MK","year":"2024","unstructured":"Turagam MK, Kawamura I, Neuzil P, et al.. Severity of ischemic stroke after left atrial appendage closure vs nonwarfarin oral anticoagulants. JACC Clin Electrophysiol. 2024, 10:270-83. 10.1016\/j.jacep.2023.10.012","journal-title":"JACC Clin Electrophysiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.24875\/RECICE.M22000320","article-title":"Left atrial appendage closure versus DOAC in elderly patients: a propensity score matching study","volume":"4","author":"Caneiro-Queija B","year":"2022","unstructured":"Caneiro-Queija B, Est\u00e9vez-Loureiro R, Raposeiras-Roub\u00edn S, et al.. Left atrial appendage closure versus DOAC in elderly patients: a propensity score matching study. REC Interv Cardiol. 2022, 4:304-310. 10.24875\/RECICE.M22000320","journal-title":"REC Interv Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12206693","article-title":"Left atrial appendage occlusion versus novel oral anticoagulation for stroke prevention in atrial fibrillation-one-year survival","volume":"12","author":"Tiosano S","year":"2023","unstructured":"Tiosano S, Banai A, Mulla W, et al.. Left atrial appendage occlusion versus novel oral anticoagulation for stroke prevention in atrial fibrillation-one-year survival. J Clin Med. 2023, 12:6693. 10.3390\/jcm12206693","journal-title":"J Clin Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2023.131188","article-title":"Direct oral anticoagulants versus percutaneous left atrial appendage occlusion in atrial fibrillation: 5-year outcomes","volume":"389","author":"Melillo F","year":"2023","unstructured":"Melillo F, Leo G, Parlati AL, et al.. Direct oral anticoagulants versus percutaneous left atrial appendage occlusion in atrial fibrillation: 5-year outcomes. Int J Cardiol. 2023, 389:131188. 10.1016\/j.ijcard.2023.131188","journal-title":"Int J Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.029421","article-title":"Clinical outcomes of left atrial appendage occlusion versus switch of direct oral antcoagulant in atrial fibrillation: a territory-wide retrospective analysis","volume":"12","author":"Ng AK","year":"2023","unstructured":"Ng AK, Ng PY, Ip A, Fung RC, Chui SF, Siu CW, Yan BP. Clinical outcomes of left atrial appendage occlusion versus switch of direct oral antcoagulant in atrial fibrillation: a territory-wide retrospective analysis. J Am Heart Assoc. 2023, 12:e029421. 10.1161\/JAHA.123.029421","journal-title":"J Am Heart Assoc"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.05.032","article-title":"Fall outcomes with left atrial appendage occlusion vs direct oral anticoagulants for atrial fibrillation","volume":"82","author":"Deng W","year":"2023","unstructured":"Deng W, Mansour M, Song B, et al.. Fall outcomes with left atrial appendage occlusion vs direct oral anticoagulants for atrial fibrillation. J Am Coll Cardiol. 2023, 82:379-81. 10.1016\/j.jacc.2023.05.032","journal-title":"J Am Coll Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-021-01983-z","article-title":"Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation","volume":"111","author":"Ding WY","year":"2022","unstructured":"Ding WY, Rivera-Caravaca JM, Fazio-Eynullayeva E, Underhill P, Gupta D, Mar\u00edn F, Lip GY. Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation. Clin Res Cardiol. 2022, 111:1040-7. 10.1007\/s00392-021-01983-z","journal-title":"Clin Res Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.repc.2020.07.021","article-title":"Non-vitamin K antagonist oral anticoagulation versus left atrial appendage occlusion for primary and secondary stroke prevention after cardioembolic stroke","volume":"40","author":"Paiva L","year":"2021","unstructured":"Paiva L, Coelho J, Barra S, Costa M, Sargento-Freitas J, Cunha L, Gon\u00e7alves L. Non-vitamin K antagonist oral anticoagulation versus left atrial appendage occlusion for primary and secondary stroke prevention after cardioembolic stroke. Rev Port Cardiol (Engl Ed). 2021, 40:357-65. 10.1016\/j.repc.2020.07.021","journal-title":"Rev Port Cardiol (Engl Ed)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.027001","article-title":"Percutaneous left atrial appendage occlusion in comparison to non-vitamin K antagonist oral anticoagulant among patients with atrial fibrillation","volume":"11","author":"Noseworthy PA","year":"2022","unstructured":"Noseworthy PA, Van Houten HK, Krumholz HM, et al.. Percutaneous left atrial appendage occlusion in comparison to non-vitamin K antagonist oral anticoagulant among patients with atrial fibrillation. J Am Heart Assoc. 2022, 11:e027001. 10.1161\/JAHA.121.027001","journal-title":"J Am Heart Assoc"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"4-year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation","volume":"79","author":"Osmancik P","year":"2022","unstructured":"Osmancik P, Herman D, Neuzil P, et al.. 4-year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation. J Am Coll Cardiol. 2022, 79:1-14. 10.1016\/j.jacc.2021.10.023","journal-title":"J Am Coll Cardiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-018-1661-y","article-title":"Hospital length of stay in patients initiated on direct oral anticoagulants versus warfarin for venous thromboembolism: a real-world single-center study","volume":"46","author":"Badreldin H","year":"2018","unstructured":"Badreldin H. Hospital length of stay in patients initiated on direct oral anticoagulants versus warfarin for venous thromboembolism: a real-world single-center study. J Thromb Thrombolysis. 2018, 46:16-21. 10.1007\/s11239-018-1661-y","journal-title":"J Thromb Thrombolysis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/296716-revisiting-left-atrial-appendage-closure-versus-oral-anticoagulants-in-recurrent-atrial-fibrillation-management-an-updated-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T19:12:25Z","timestamp":1728069145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/296716-revisiting-left-atrial-appendage-closure-versus-oral-anticoagulants-in-recurrent-atrial-fibrillation-management-an-updated-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,4]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.70854","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,4]]}}}